These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 18928957)

  • 1. Coronary artery aneurysm formation after drug-eluting stent implantation.
    Levisay JP; Roth RM; Schatz RA
    Cardiovasc Revasc Med; 2008; 9(4):284-7. PubMed ID: 18928957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent very late stent thrombosis after bare-metal stent implantation.
    Saito T; Asajima H
    Catheter Cardiovasc Interv; 2007 Jul; 70(1):51-3. PubMed ID: 17295327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of patients with in-stent restenosis.
    Alfonso F; Pérez-Vizcayno MJ; Cruz A; García J; Jimenez-Quevedo P; Escaned J; Hernandez R
    EuroIntervention; 2009 May; 5 Suppl D():D70-8. PubMed ID: 19736076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late stent thrombosis associated with coronary aneurysm formation after sirolimus-eluting stent implantation.
    Aziz S; Morris JL; Perry RA
    J Invasive Cardiol; 2007 Apr; 19(4):E96-8. PubMed ID: 17404416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
    Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Pastori F; De Luca L; Zavalloni D; Soregaroli D; Garbo R; Franchi E; Marino P; Minelli M; Vassanelli C
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):192-9. PubMed ID: 19377384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of thrombosis after implantation of drug-eluting stents in patients with coronary artery disease.
    Chen JL; Yang YJ; Gao LJ; Huang JH; Qin XW; Qiao SB; Xu B; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Li JJ; Gao RL
    Chin Med J (Engl); 2008 Nov; 121(21):2144-7. PubMed ID: 19080174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents.
    Steinberg DH; Gaglia MA; Pinto Slottow TL; Roy P; Bonello L; De Labriolle A; Lemesle G; Torguson R; Kineshige K; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2009 Feb; 103(4):491-5. PubMed ID: 19195508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of the real-world use of drug-eluting stents at 9-month follow-up: results from the Sicilian DES Registry.
    Tamburino C; Barbagallo R; Capodanno D; di Matteo S; Colombo GL; Recchia M; Ciriminna S;
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):322-9. PubMed ID: 19430343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
    Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR
    Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-eluting stent thrombosis.
    Stähli BE; Camici GG; Tanner FC
    Ther Adv Cardiovasc Dis; 2009 Feb; 3(1):45-52. PubMed ID: 19124388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet therapy in the era of drug-eluting stents: current and future perspectives.
    Ducrocq G; Serebruany V; Tanguay JF
    Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):939-53. PubMed ID: 17867923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous treatment of a coronary aneurysm by stent graft and drug-eluting stent implantation: a potential method to reduce stent graft restenosis.
    Süselbeck T; Haghi D; Borggrefe M; Kaden JJ
    J Interv Cardiol; 2008 Aug; 21(4):325-8. PubMed ID: 18754968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel paclitaxel-eluting dedicated bifurcation stent: a case report from the first human use Taxus Petal trial.
    Johnson TW; Kay IP; Ormiston JA
    Catheter Cardiovasc Interv; 2009 Apr; 73(5):637-40. PubMed ID: 19213074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiographic and clinical outcome of invasively managed patients with thrombosed coronary bare metal or drug-eluting stents: the OPTIMIST study.
    Burzotta F; Parma A; Pristipino C; Manzoli A; Belloni F; Sardella G; Rigattieri S; Danesi A; Mazzarotto P; Summaria F; Romagnoli E; Prati F; Trani C; Crea F
    Eur Heart J; 2008 Dec; 29(24):3011-21. PubMed ID: 18987096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent very late drug-eluting stent thrombosis.
    Pesarini G; Arieti M; Spadaro R; Vassanelli C; Ribichini F
    Cardiovasc Revasc Med; 2009; 10(2):130-5. PubMed ID: 19327678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries.
    Bonello L; De Labriolle A; Lemesle G; Roy P; Steinberg DH; Slottow TL; Xue Z; Torguson R; Kaneshige K; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R
    Am J Cardiol; 2009 Feb; 103(4):496-500. PubMed ID: 19195509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time does not heal every wound: coronary stent thrombosis of a bare-metal stent more than one decade after its implantation.
    Zomer AC; Zwart B; van Werkum JW; Suttorp MJ
    Platelets; 2009 Dec; 20(8):594-7. PubMed ID: 19857047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Very late coronary aneurysm formation with subsequent stent thrombosis secondary to drug-eluting stent.
    Akin I; Kische S; Rehders TC; Schneider H; Turan GR; Kleinfeldt T; Ortak J; Ince H; Nienaber CA
    Chin Med J (Engl); 2011 Oct; 124(20):3427-9. PubMed ID: 22088549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of long-term outcomes of bare metal or drug-eluting stent implantation in standard versus off-label coronary narrowings.
    Harjai KJ; Orshaw P; Boura J; Sporn D
    Am J Cardiol; 2009 Jun; 103(11):1537-45. PubMed ID: 19463512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term results of unprotected left main percutaneous coronary intervention with DES versus BMS.
    Capodanno D; Di Salvo ME; Capranzano P; Seminara D; Caggegi A; Barrano G; Tamburino C
    Minerva Cardioangiol; 2009 Feb; 57(1):1-6. PubMed ID: 19202514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.